WIPO trademark

Trinomab

RegisteredWIPOClass 5Class 35Class 42Class 44

"Trinomab" is a trademark owned by Zhuhai Trinomab Pharmaceutical Co., Ltd., filed at the WIPO on July 12, 2022. It is registered and covers classes 5, 35, 42 and 44.

Trinomab
Trademark as filed with the WIPO
Status
Registered
Filed
July 12, 2022
Registered
Not yet
Expires
July 12, 2032
Application no.
Not recorded
Registration no.
1683959
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
4 classes
Ownership

Who owns Trinomab

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services Trinomab is filed for, grouped by Nice class.

  • Chemical reagents for medical or veterinary purposes; biochemical drugs; pharmaceutical preparations; medicines for human purposes; diagnostic preparations for medical purposes; chemico-pharmaceutical preparations; vaccines; drugs for medical purposes; biological preparations for medical purposes; chemical preparations for pharmaceutical purposes.

  • Retail or wholesale services for veterinary drugs; retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail or wholesale services for drugs.

  • Scientific research; technological research; conducting technical project studies; scientific laboratory services; research and development of new products for others; chemical analysis; chemical research; biological research; clinical trials; chemistry services.

  • Hospital services; medical assistance; nursing, medical; therapy services; alternative medicine services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; blood collection services; performing diagnosis of diseases; collection and preservation of human blood; genetic testing for medical purposes; behavioral analysis for medical purposes; rental of medical instruments and apparatus; stem cell therapy services; veterinary assistance.

FAQ

About Trinomab

Who owns the trademark "Trinomab"?

The WIPO trademark "Trinomab" is owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.

What is the status of "Trinomab"?

Its status at the WIPO is: registered.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Trinomab and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_6402522a-fd0f-414e-ae18-d7a42b43f976
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_6402522a-fd0f-414e-ae18-d7a42b43f976",
  "object": "trademark",
  "mark_text": "Trinomab",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2022-07-12",
  "nice_classes": [
    5,
    35,
    42,
    44
  ],
  "owners": [
    {
      "name": "Zhuhai Trinomab Pharmaceutical Co., Ltd.",
      "entity_id": "ent_019ebb64-8b23-733c-9a8b-efcae9acbffe"
    }
  ]
}